U.S. Biobanks Market (2025 - 2030) Size, Share & Trends Analysis Report By Product & Service, By Biospecimen (Human Tissues, Organs, Stem Cells), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Market Definitions
                       1.2.1. Products & Services Segment
                       1.2.2. Biospecimen Segment
                       1.2.3. Type Segment
                       1.2.4. Application Segment
                   1.3. Information analysis
                   1.4. Market formulation & data visualization
                   1.5. Data validation & publishing
                   1.6. Information Procurement
                       1.6.1. Primary Research
                   1.7. Information or Data Analysis
                   1.8. Market Formulation & Validation
                   1.9. Market Model
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increased focus on precision medicine and genetic testing
                           3.2.1.2. Changes in biobanking operations
                           3.2.1.3. Increase in the number of clinical trials
                           3.2.1.4. Growing biobanking industry and research collaborations
                           3.2.1.5. Technology advancement and automation
                       3.2.2. Market restraint analysis
                           3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
                           3.2.2.2. Sustainability challenges for biobanks
                           3.2.2.3. Challenges associated with biobanking specimen management
                   3.3. U.S. Biobanks Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Biobanks Market: Ingredient Estimates & Trend Analysis
                   4.1. Products & Services Segment Dashboard
                   4.2. U.S. Biobanks Market Products & Services Movement Analysis
                   4.3. U.S. Biobanks Market Size & Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
                   4.4. Products
                       4.4.1. Products Market, 2018 - 2030 (USD Million)
                       4.4.2. Biobanking Equipment
                           4.4.2.1. Biobanking Equipment Market, 2018 - 2030 (USD Million)
                           4.4.2.2. Temperature Control Systems
                               4.4.2.2.1. Temperature Control Systems Market, 2018 - 2030 (USD Million)
                               4.4.2.2.2. Freezers & Refrigerators
                                   4.4.2.2.2.1. Freezers & Refrigerators Market, 2018 - 2030 (USD Million)
                               4.4.2.2.3. Cryogenic Storage Systems
                                   4.4.2.2.3.1. Cryogenic Storage Systems Market, 2018 - 2030 (USD Million)
                               4.4.2.2.4. Thawing Equipment
                                   4.4.2.2.4.1. Thawing Equipment Market, 2018 - 2030 (USD Million)
                           4.4.2.3. Incubators & Centrifuges
                               4.4.2.3.1. Incubators & Centrifuges Market, 2018 - 2030 (USD Million)
                           4.4.2.4. Alarms & Monitoring Systems
                               4.4.2.4.1. Alarms & Monitoring Systems Market, 2018 - 2030 (USD Million)
                           4.4.2.5. Accessories & Other Equipment
                               4.4.2.5.1. Accessories & Other Equipment Market, 2018 - 2030 (USD Million)
                       4.4.3. Biobanking Consumables
                           4.4.3.1. Biobanking Consumables Market, 2018 - 2030 (USD Million)
                       4.4.4. Laboratory Information Management Systems
                           4.4.4.1. Laboratory Information Management Systems Market, 2018 - 2030 (USD Million)
                   4.5. Services
                       4.5.1. Services Market, 2018 - 2030 (USD Million)
                       4.5.2. Biobanking & Repository
                           4.5.2.1. Biobanking & Repository Market, 2018 - 2030 (USD Million)
                       4.5.3. Lab processing
                           4.5.3.1. Lab processing Market, 2018 - 2030 (USD Million)
                       4.5.4. Qualification/ Validation
                           4.5.4.1. Qualification/ Validation Market, 2018 - 2030 (USD Million)
                       4.5.5. Cold Chain Logistics
                           4.5.5.1. Cold Chain Logistics Market, 2018 - 2030 (USD Million)
                       4.5.6. Other Services
                           4.5.6.1. Other Services Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Biobanks Market: Biospecimen Estimates & Trend Analysis
                   5.1. Biospecimen Segment Dashboard
                   5.2. U.S. Biobanks Market Biospecimen Movement Analysis
                   5.3. U.S. Biobanks Market Size & Trend Analysis, by Biospecimen, 2018 to 2030 (USD Million)
                   5.4. Human Tissues
                       5.4.1. Human Tissues Market, 2018 - 2030 (USD Million)
                   5.5. Organs
                       5.5.1. Organs Market, 2018 - 2030 (USD Million)
                   5.6. Stem Cells
                       5.6.1. Stem Cells Market, 2018 - 2030 (USD Million)
                       5.6.2. Adult Stem Cells
                           5.6.2.1. Adult Stem Cells Market, 2018 - 2030 (USD Million)
                       5.6.3. Embryonic Stem Cells
                           5.6.3.1. Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
                       5.6.4. IPS Cells
                           5.6.4.1. IPS Cells Market, 2018 - 2030 (USD Million)
                       5.6.5. Other Stem Cells
                           5.6.5.1. Other Stem Cells Market, 2018 - 2030 (USD Million)
                   5.7. Other Biospecimens
                       5.7.1. Other Biospecimens Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Biobanks Market: Type Estimates & Trend Analysis
                   6.1. Type Segment Dashboard
                   6.2. U.S. Biobanks Market Type Movement Analysis
                   6.3. U.S. Biobanks Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
                   6.4. Physical/Real Biobanks
                       6.4.1. Physical/Real Biobanks Market, 2018 - 2030 (USD Million)
                       6.4.2. Tissue Biobanks
                           6.4.2.1. Tissue Biobanks Market, 2018 - 2030 (USD Million)
                       6.4.3. Population Based Biobanks
                           6.4.3.1. Population Based Biobanks Market, 2018 - 2030 (USD Million)
                       6.4.4. Genetic (DNA/RNA)
                           6.4.4.1. Genetic (DNA/RNA) Market, 2018 - 2030 (USD Million)
                       6.4.5. Disease Based Biobanks
                           6.4.5.1. Disease Based Biobanks Market, 2018 - 2030 (USD Million)
                   6.5. Virtual Biobanks
                       6.5.1. Virtual Biobanks Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Biobanks Market: Application Estimates & Trend Analysis
                   7.1. Application Segment Dashboard
                   7.2. U.S. Biobanks Market Application Movement Analysis
                   7.3. U.S. Biobanks Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
                   7.4. Therapeutics
                       7.4.1. Therapeutics Market, 2018 - 2030 (USD Million)
                   7.5. Drug Discovery & Clinical Research
                       7.5.1. Drug Discovery & Clinical Research Market, 2018 - 2030 (USD Million)
                   7.6. Clinical Diagnostics
                       7.6.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
                   7.7. Other Application
                       7.7.1. Other Application Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Company Categorization
                   8.2. Strategy Mapping
                   8.3. Company Profiles/Listing
                       8.3.1. Thermo Fisher Scientific, Inc.
                           8.3.1.1. Overview
                           8.3.1.2. Financial Performance
                           8.3.1.3. Product Benchmarking
                           8.3.1.4. Strategic Initiatives
                       8.3.2. Merck KGaA
                           8.3.2.1. Overview
                           8.3.2.2. Financial Performance
                           8.3.2.3. Product Benchmarking
                           8.3.2.4. Strategic Initiatives
                       8.3.3. QIAGEN
                           8.3.3.1. Overview
                           8.3.3.2. Financial Performance
                           8.3.3.3. Product Benchmarking
                           8.3.3.4. Strategic Initiatives
                       8.3.4. Hamilton Company
                           8.3.4.1. Overview
                           8.3.4.2. Financial Performance
                           8.3.4.3. Product Benchmarking
                           8.3.4.4. Strategic Initiatives
                       8.3.5. Tecan Trading Ag
                           8.3.5.1. Overview
                           8.3.5.2. Financial Performance
                           8.3.5.3. Product Benchmarking
                           8.3.5.4. Strategic Initiatives
                       8.3.6. ViaCord (Revitty)
                           8.3.6.1. Overview
                           8.3.6.2. Financial Performance
                           8.3.6.3. Product Benchmarking
                           8.3.6.4. Strategic Initiatives
                       8.3.7. Cryo-Cell
                           8.3.7.1. Overview
                           8.3.7.2. Financial Performance
                           8.3.7.3. Product Benchmarking
                           8.3.7.4. Strategic Initiatives
                       8.3.8. BioCision, Llc.
                           8.3.8.1. Overview
                           8.3.8.2. Financial Performance
                           8.3.8.3. Product Benchmarking
                           8.3.8.4. Strategic Initiatives
                       8.3.9. Icbiomedical
                           8.3.9.1. Overview
                           8.3.9.2. Financial Performance
                           8.3.9.3. Product Benchmarking
                           8.3.9.4. Strategic Initiatives
                       8.3.10. Charles River Laboratories
                           8.3.10.1. Overview
                           8.3.10.2. Financial Performance
                           8.3.10.3. Product Benchmarking
                           8.3.10.4. Strategic Initiatives
                       8.3.11. Azenta US Inc.
                           8.3.11.1. Overview
                           8.3.11.2. Financial Performance
                           8.3.11.3. Product Benchmarking
                           8.3.11.4. Strategic Initiatives
                       8.3.12. Stemcell Technologies
                           8.3.12.1. Overview
                           8.3.12.2. Financial Performance
                           8.3.12.3. Product Benchmarking
                           8.3.12.4. Strategic Initiatives
                       8.3.13. Biovault Family
                           8.3.13.1. Overview
                           8.3.13.2. Financial Performance
                           8.3.13.3. Product Benchmarking
                           8.3.13.4. Strategic Initiatives
                       8.3.14. LabVantage Solutions Inc.
                           8.3.14.1. Overview
                           8.3.14.2. Financial Performance
                           8.3.14.3. Product Benchmarking
                           8.3.14.4. Strategic Initiatives
                       8.3.15. Precision Cellular Storage Ltd.
                           8.3.15.1. Overview
                           8.3.15.2. Financial Performance
                           8.3.15.3. Product Benchmarking
                           8.3.15.4. Strategic Initiatives

List of Tables

Table 1. U.S. biobanks market estimates & forecasts
Table 2. U.S. biobanks market estimates & forecasts, by products & services, 2018 - 2030 (USD Million)
Table 3. U.S. biobanks market estimates & forecasts, by biospecimen, 2018 - 2030 (USD Million)
Table 4. U.S. biobanks market estimates & forecasts, by type, 2018 - 2030 (USD Million)
Table 5. U.S. biobanks market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market snapshot
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Market trends & outlook
Fig. 7 Market segmentation & scope
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 PESTLE Analysis
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Strategy framework
Fig. 13 Participant categorization
Fig. 14 U.S. biobanks market: Products & services outlook key takeaways
Fig. 15 U.S. biobanks market: Products & services movement analysis
Fig. 16 Products market, 2018 - 2030 (USD Million)
Fig. 17 Biobanking equipment market, 2018 - 2030 (USD Million)
Fig. 18 Temperature control systems market, 2018 - 2030 (USD Million)
Fig. 19 Freezers & refrigerators market, 2018 - 2030 (USD Million)
Fig. 20 Cryogenic storage systems market, 2018 - 2030 (USD Million)
Fig. 21 Thawing equipment market, 2018 - 2030 (USD Million)
Fig. 22 Incubators & centrifuges market, 2018 - 2030 (USD Million)
Fig. 23 Alarms & monitoring systems market, 2018 - 2030 (USD Million)
Fig. 24 Accessories & other equipment market, 2018 - 2030 (USD Million)
Fig. 25 Biobanking consumables market, 2018 - 2030 (USD Million)
Fig. 26 Laboratory information management systems market, 2018 - 2030 (USD Million)
Fig. 27 Services market, 2018 - 2030 (USD Million)
Fig. 28 Biobanking & repository market, 2018 - 2030 (USD Million)
Fig. 29 Lab processing market, 2018 - 2030 (USD Million)
Fig. 30 Qualification/validation market, 2018 - 2030 (USD Million)
Fig. 31 Cold chain logistics market, 2018 - 2030 (USD Million)
Fig. 32 Other services market, 2018 - 2030 (USD Million)
Fig. 33 U.S. biobanks market: Biospecimen outlook key takeaways
Fig. 34 U.S. biobanks market: Biospecimen movement analysis
Fig. 35 Human tissues market, 2018 - 2030 (USD Million)
Fig. 36 Organs market, 2018 - 2030 (USD Million)
Fig. 37 Stem cells tissues market, 2018 - 2030 (USD Million)
Fig. 38 Adult stem cells market, 2018 - 2030 (USD Million)
Fig. 39 Embryonic stem cells market, 2018 - 2030 (USD Million)
Fig. 40 IPS cells market, 2018 - 2030 (USD Million)
Fig. 41 Other stem cells market, 2018 - 2030 (USD Million)
Fig. 42 Other biospecimens market, 2018 - 2030 (USD Million)
Fig. 43 U.S. biobanks market: Type outlook key takeaways
Fig. 44 U.S. biobanks market: Type movement analysis
Fig. 45 Physical/real biobanks market, 2018 - 2030 (USD Million)
Fig. 46 Tissue biobanks market, 2018 - 2030 (USD Million)
Fig. 47 Population-based biobanks market, 2018 - 2030 (USD Million)
Fig. 48 Genetic (DNA/RNA) market, 2018 - 2030 (USD Million)
Fig. 49 Disease-based biobanks market, 2018 - 2030 (USD Million)
Fig. 50 Virtual biobanks market, 2018 - 2030 (USD Million)
Fig. 51 U.S. biobanks market: Application outlook key takeaways
Fig. 52 U.S. biobanks market: Application movement analysis
Fig. 53 Therapeutics market, 2018 - 2030 (USD Million)
Fig. 54 Drug discovery & clinical research market, 2018 - 2030 (USD Million)
Fig. 55 Clinical diagnostics market, 2018 - 2030 (USD Million)
Fig. 56 Other application market, 2018 - 2030 (USD Million)
Fig. 57 U.S. biobanks market, 2018 - 2030 (USD Million)
Fig. 58 Key companies profiled